Evidence map›Paper›PMID 41102727›Full record

ReviewDiagnostic pathology2025

EWSR1::BEND2 fusion sarcoma of the urinary bladder - a case report and review of literature.

Vili Halava, Jenni Tuominen, Paula Lindholm, Timo Kyyrönen, Markku Kallajoki, Katri Orte

Abstract readCase ReportsReview
In one paragraph

Review in Diagnostic pathology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Vili HalavaDepartment of Pathology, TYKS Laboratories, Turku University Hospital and University of Turku, Turku, Finland.
Jenni TuominenLaboratory of Molecular Haematology and Pathology, Department of Genomics, TYKS Laboratories, Turku University Hospital and University of Turku, Turku, Finland.
Paula LindholmDepartment of Oncology, Turku University Hospital and University of Turku, Turku, Finland.
Timo KyyrönenDepartment of Radiology, Turku University Hospital and University of Turku, Turku, Finland.
Markku KallajokiDepartment of Pathology, TYKS Laboratories, Turku University Hospital and University of Turku, Turku, Finland.
Katri OrteDepartment of Pathology, TYKS Laboratories, Turku University Hospital and University of Turku, Turku, Finland. katri.orte@tyks.fi.ORCID http://orcid.org/0000-0002-0353-6826

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this case report we describe a Ewing-like high grade small round cell sarcoma of the urinary bladder in which an extremely rare EWSR1::BEND2 fusion was found. A 28-year-old male patient presented with hematuria and in the following examinations a large necrotic bladder tumor with spreading to adjacent prostatic tissue and multiple lung metastases were found. Histology showed a poorly differentiated small round cell tumor with perivascular rosettes and moderate membranous positivity for CD99. The methylation profile of the tumor did not match with any of the tumor entities grouped by the sarcoma classifier. With tumor agnostic methods, mainly next generation sequencing, novel fusions are being found at an accelerating rate. Our case adds to the expanding group of EWSR1 fusion neoplasms, and describes the effects of a Ewing sarcoma treatment protocol on this type of sarcoma. The relevance of traditional methods for detecting Ewing sarcoma with fluorescence in situ hybridization is decreasing as EWSR1 rearrangements are detected in tumors that show different clinical behavior and morphology. The classification of these tumors into WHO defined entities to guide treatment is a challenge.

Indexed as

Biomarkers, TumorOncogene Proteins, FusionRNA-Binding Protein EWSSarcoma, EwingSarcoma, Small CellUrinary Bladder NeoplasmsAdultHumansIn Situ Hybridization, FluorescenceMaleBiomarkers, TumorEWSR1 protein, humanOncogene Proteins, FusionRNA-Binding Protein EWSEwing-like sarcomaEWSR1:BEND2Fusion sarcomaUndifferentiated small round cell sarcoma

Identifiers

PMID41102727
PMCPMC12533323

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.